Skip to content

Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCT

Effectiveness of a Program of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke: A Multi-site RCT

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00885456
Acronym
PREVENT
Enrollment
187
Registered
2009-04-22
Start date
2011-10-30
Completion date
2017-06-30
Last updated
2018-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-disabling Stroke, Transient Ischemic Attack

Keywords

stroke, secondary prevention, vascular risk, behavioral change, exercise, lifestyle modification

Brief summary

The objective of the Program of Rehabilitative Exercise and Education to avert Vascular Events after Non-disabling stroke and Transient ischemic attack (PREVENT) Trial is to determine whether the timely delivery of secondary stroke prevention strategies will reduce modifiable vascular risk factors in two groups of people who have survived NDS or TIA. One group will receive a comprehensive education and exercise program (PREVENT); the other group will receive usual care (USUAL CARE). We will measure modifiable vascular risk factors in both groups. We will also compare the effects of PREVENT vs USUAL CARE on exercise capacity, walking endurance, and daily physical activity. In addition, we will compare thinking ability, depression, achievement of personal goals for healthy behavior, and health-related goal attainment and health-related quality of life. Finally, we will compare outcomes in urban and rural settings as well as costs of the PREVENT program and USUAL CARE in order to assess sustainability of the PREVENT program.

Interventions

BEHAVIORALPREVENT program

12-week program of aerobic/strengthening exercises and education designed to induce physiological and behavioral changes deemed necessary to reduce vascular risk

BEHAVIORALUsual Care

Three or more out-patient visits to the neurovascular clinic for assessment, counseling and referral to appropriate health care professionals.

Sponsors

Heart and Stroke Foundation of Canada
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Canadian Stroke Network
CollaboratorOTHER
Marilyn MacKay-Lyons
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females * Over 17 years of age. * Diagnosis of first probable or definite TIA or non-disabling stroke (National Institutes of Health Stroke Scale \< 6) * Post-event interval of \<90 days. * Residence within 75 km of intervention site. * Orientation to time, place and person and ability to follow simple 3-step commands. * Ability and willingness to provide informed consent.

Exclusion criteria

* Evidence of intracranial hemorrhage on MRI or CT scan. * Presence of contraindications to exercise testing and training, in accordance with American College of Sports Medicine Guidelines. * Participation in another study that could potentially confound the outcomes of this trial.

Design outcomes

Primary

MeasureTime frame
12-hour fasting glucose/hemoglobin A1Cbaseline, post-intervention, 6 months, 12 months
systolic blood pressure (primary vascular risk factor being assessed)baseline, post-intervention, 6 months, 12 months
diastolic blood pressurebaseline, post-intervention, 6 months, 12 months
waist circumferencebaseline, post-intervention, 6 months, 12 months
12-hour fasting lipid profilebaseline, post-intervention, 6 months, 12 months

Secondary

MeasureTime frame
cognitionbaseline, 12 months
depressionbaseline, post-intervention, 6 months, 12 months
health-related quality of lifebaseline, post-intervention, 6 months, 12 months
exercise capacitybaseline, post-intervention, 12 months
direct health costsbaseline, post-intervention, 6 months, 12 months
secondary vascular eventsbaseline, post-intervention, 6 months, 12 months
daily step countbaseline, post-intervention, 12 months
health-related goal attainmentbaseline, post-intervention, 6 months, 12 months
daily physical activitybaseline, post-intervention, 6 months, 12 months
walking endurancebaseline, post-intervention, 6 months, 12 months
cigarette smokingbaseline, post-intervention, 6 months, 12 months
medication adherencebaseline, post-intervention, 6 months, 12 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026